Facebook
Twitter
Telegram
Report an ErrorFoghorn Therapeutics Financial Statements 2011-2024 | FHTX
Annual Financial Statements Foghorn Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
291 M | 219 M | 850 M | 221 M | - | - | - | - | - | - | - | - | - |
Shares |
42 M | 41.6 M | 37.2 M | 11 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
6.94 | 5.27 | 22.9 | 20.3 | - | - | - | - | - | - | - | - | - |
Net Income |
-98.4 M | -109 M | -101 M | -68.8 M | -51.1 M | -26.3 M | - | - | - | - | - | - | - |
Revenue |
34.2 M | 19.2 M | 1.32 M | 430 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-108 M | -117 M | -101 M | -68.5 M | -51.1 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 2.49 M | 979 K | 540 K | - | - | - | - | - | - | - | - |
EBITDA |
-104 M | -114 M | -97.5 M | -67.2 M | -50.4 M | -25.7 M | - | - | - | - | - | - | - |
Operating Expenses |
142 M | 136 M | 102 M | 69 M | 51.1 M | 26 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
32.4 M | 30.7 M | 21.7 M | 11.2 M | 6.72 M | 4.82 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Foghorn Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
42.4 M | 42.3 M | 42 M | 41.8 M | 41.8 M | 41.8 M | 41.7 M | 41.5 M | 41.4 M | 41.3 M | 37 M | 36.8 M | 36.8 M | 36.8 M | 5.88 M | 5.42 M | 5.15 M | 4.87 M | 4.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-25 M | - | -14.3 M | -29.5 M | -30.5 M | - | -25.8 M | -27.3 M | -26.9 M | - | -26.1 M | -23.1 M | -23 M | - | -18.4 M | -15.7 M | -14 M | - | -51.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
5.05 M | - | 17.5 M | 5.6 M | 5.31 M | - | 6.63 M | 4.49 M | 3.92 M | - | 41 K | 279 K | 286 K | - | 179 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-28.2 M | - | -17.1 M | -32 M | -33.3 M | - | -28.3 M | -29.2 M | -27.8 M | - | -26.3 M | -23.3 M | -23.1 M | - | -18.5 M | -15.5 M | -13.7 M | - | -13.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | 499 K | 495 K | 486 K | - | 202 K | 198 K | 258 K | - | 113 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-27.4 M | - | -16.2 M | -31.2 M | -32.5 M | - | -27.4 M | -28.4 M | -27 M | - | -25.5 M | -22.5 M | -22.4 M | - | -18.2 M | -15.3 M | -13.5 M | - | -12.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
33.2 M | - | 34.6 M | 37.6 M | 38.6 M | - | 34.9 M | 33.7 M | 31.7 M | - | 26.3 M | 23.5 M | 23.4 M | - | 18.7 M | 15.5 M | 13.7 M | - | 13.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.71 M | - | 8.31 M | 8.4 M | 8.64 M | - | 7.96 M | 7.7 M | 7.22 M | - | 5.81 M | 4.9 M | 4.69 M | - | 2.56 M | 1.91 M | 2.22 M | - | 1.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency